IMMUNODEFICIENCY, COMMON VARIABLE, 2
|
disease |
|
Disease or Syndrome
|
1
|
9
|
0.600 |
None |
1.000 |
20 |
9
|
2005 |
2017 |
Acquired Hypogammaglobulinemia
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
89
|
4
|
0.400 |
None |
1.000 |
19 |
2
|
1999 |
2014 |
Autoimmune Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
1758
|
428
|
0.100 |
None |
1.000 |
13 |
2
|
1986 |
2018 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.280 |
None |
1.000 |
10 |
2
|
2001 |
2019 |
Immunoglobulin A deficiency (disorder)
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
72
|
25
|
0.070 |
None |
1.000 |
7 |
|
2005 |
2009 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1740
|
865
|
0.450 |
None |
1.000 |
7 |
2
|
2004 |
2019 |
Hypogammaglobulinemia
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
76
|
2
|
0.050 |
None |
1.000 |
5 |
2
|
1999 |
2019 |
Antibody Deficiency Syndrome
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
21
|
|
0.040 |
None |
1.000 |
4 |
|
2008 |
2016 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.040 |
None |
1.000 |
4 |
|
1986 |
2020 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1548
|
91
|
0.140 |
None |
1.000 |
4 |
|
1999 |
2012 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.030 |
None |
1.000 |
3 |
|
2007 |
2012 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2012 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2012 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.130 |
None |
1.000 |
3 |
|
2009 |
2017 |
Septicemia
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
1285
|
141
|
0.020 |
None |
1.000 |
2 |
1
|
2015 |
2018 |
Chronic Lymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1447
|
291
|
0.020 |
None |
1.000 |
2 |
1
|
2013 |
2015 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
1986 |
2020 |
Smith-Magenis syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
47
|
8
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2015 |
Monoclonal Gammopathy of Undetermined Significance
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
227
|
20
|
0.110 |
None |
1.000 |
2 |
2
|
2015 |
2019 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
2 |
11
|
2012 |
2018 |
Sepsis
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
1453
|
144
|
0.020 |
None |
1.000 |
2 |
1
|
2015 |
2018 |
Immune thrombocytopenic purpura
|
disease |
Pathological Conditions, Signs and Symptoms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
338
|
35
|
0.120 |
None |
1.000 |
2 |
1
|
2014 |
2017 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2011 |
Lupus Nephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
503
|
64
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2018 |
Protein measurement
|
group |
|
Laboratory Procedure
|
75
|
422
|
0.100 |
None |
1.000 |
2 |
2
|
2010 |
2012 |